Paradigm Biopharmaceuticals reported AUD87.8M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Avita Medical AUD 105.47M 35.32M Dec/2025
Medical Developments International AUD 62.53M 563.29K Dec/2025
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Pacific Edge NZD 177.94M 16.27M Jun/2026
PYC Therapeutics AUD 965.3M 209.97M Dec/2025
Telix Pharmaceuticals AUD 7.81B 2.74B Jun/2026